#Dr Reddy&039;s

[don-lichterman]

Stocks in news: Wipro, Tata Motors, Dr Reddy's, RITES and more

Stocks in news: Wipro, Tata Motors, Dr Reddy’s, RITES and more

The market ended lower on Thursday amid weak global cues. Sensex tanked 1,045 points to 51,495 and Nifty ended 331 points lower at 15,360. Market fell for the fourth consecutive session ahead of Federal Reserve’s policy announcement on Wednesday. Sensex fell 152 points to 52,541 and Nifty closed 40 points lower at 15,692. Tata Steel, Tech Mahindra and Bharti Airtel were the top Sensex losers…

[netionaldastak]

UoH, Dr Reddy’s join hands to develop blockchain solutions for pharma industry

UoH, Dr Reddy’s join hands to develop blockchain solutions for pharma industry

The University of Hyderabad (UoH) and pharma major Dr Reddy’s Laboratories Ltd will be jointly developing cold chain logistics solutions for pharmaceutical firms based on blockchain. Vijaya Bhaskar Marisetty and Varsha Mamidi, School of Management Studies at the University of Hyderabad (UoH) will lead a project, in partnership with Hyderabad-based Dr Reddy’s to develop cold chainlogistics…

[newsclick01]

Don't See Covid Pills As Driver Of Profit, Says

Don’t See Covid Pills As Driver Of Profit, Says

Dr Reddy’s is expecting regulatory nod to produce Merck’s antiviral drug molnupiravir within weeks. For a drugmaker licensed to produce Merck & Co.’s promising Covid-19 pill and sell Russia’s Sputnik V shot, Dr Reddy’s Laboratories Ltd. is surprisingly mellow about the rewards it expects from these medical breakthroughs even as virus waves continue to hit parts of the world. “Covid portfolios…

[doonitedin]

Dr. Reddy's Laboratories Ltd on Monday announced the commercial launch of 2-deoxy-D-glucose

Dr. Reddy’s Laboratories Ltd on Monday announced the commercial launch of 2-deoxy-D-glucose

          The company will make the drug available in hospitals across metros and Tier 1 cities in the initial weeks. Dr. Reddy’s Laboratories Ltd on Monday announced the commercial launch of 2-deoxy-D-glucose (2-DG). According to a press release issued by the city-based drug maker, Dr. Reddy’s will supply the drug to major government as well as private hospitals across India. In the initial…

[hummingzone]

Exclusive: Mumbai Gets 3 Bids From Russia's Sputnik Covid Vaccine Makers

Exclusive: Mumbai Gets 3 Bids From Russia’s Sputnik Covid Vaccine Makers

RDIF has said it will transfer one crore Sputnik V doses to BMC in 60 days. New Delhi: Mumbai has received three bids for the supply of Russia’s Sputnik V Covid vaccine, government sources have said. The city’s civic body had earlier this month placed global tenders for one crore doses. The Brihamumbai Municipal Corporation (BMC) had placed the tenders on May 11. These were issued under India’s…

[telugugachips]

2-డీజీ ఫస్ట్‌ బ్యాచ్‌ను విడుదల చేసిన కేంద్రమంత్రి రాజ్‌నాథ్‌ సింగ్.

న్యూఢిల్���ీ:  డాక్టర్ రెడ్డీస్‌, డీఆర్‌డీవో అభివృద్ధి చేసిన కోవిడ్‌–19 ఔషధం ‘2– డీజీ’ తొలిబ్యాచ్‌ను కేంద్రమంత్రి రాజ్‌నాథ్‌ సింగ్ విడుదల చేశారు. నోటి ద్వారా తీసుకునే 2–డీజీ ఔషధాన్ని ఒక మోస్తరు నుంచి వ్యాధి తీవ్రత అధికంగా ఉన్న పేషెంట్ల చికిత్సలో వాడటానికి భారత ఔషధ నియంత్రణ సంస్థ (డీసీజీఐ) అనుమతించిన విషయం తెలిసిందే. 2– డీఆక్సీ– డీ– గ్లూకోజ్‌ (క్లుప్తంగా 2–డీజీ) ఆసుపత్రిలో చేరిన కరోనా బాధితులు…

[breaking-news-portal]

Second batch of Russian COVID-19 vaccine reaches Hyderabad

Second batch of Russian COVID-19 vaccine reaches Hyderabad

As many as 60,000 doses of the second batch of Russia’s COVID-19 vaccine Sputnik V on Sunday landed at Rajiv Gandhi International Airport here, Dr Reddy’s Laboratories said on Sunday. “Pleased to share that the consignment that arrived today in Hyderabad contains 60,000 doses of the second dose component of the #SputnikV vaccine. Samples from the consignment will be sent for release to the…

[bbbnews]

Dr Reddy's, Russian Firm RDIF Begin Clinical Trials For Covid Vaccine Sputnik V In India

Dr Reddy’s, Russian Firm RDIF Begin Clinical Trials For Covid Vaccine Sputnik V In India

<!-- -->

Sputnik V became the world’s first registered Covid vaccine based on human adenoviral vector platform

Dr Reddy’s Laboratories and the Russian Direct Investment Fund (RDIF) on Tuesday announced the start of adaptive phase 2/3 clinical trials for COVID-19 vaccine Sputnik V in India after receiving necessary clearance from the Central Drugs Laboratory in Himachal Pradesh.

The Indian…

[weelectronicstudentreviewstuff]

Dr Reddy’s Stock Price Jumps On Nod to hold trials for Russia’s Sputnik V COVID-19 Vaccine Dr Reddy's Labs Share Price: The stock rose to as high as Rs 5,213.50 on the BSE during the session…

[newsyaari]

Dr Reddy’s Reapplies For Clinical Trials Of Russian COVID-19 Vaccine Sputnik V: Report Dr Reddy's reapplies for phases 2,3 clinical trials of Russian COVID-19 vaccine (Representational) New Delhi: The Hyderabad-based Dr Reddy's Laboratories has reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phases 2 and 3 human clinical trials of the Russian COVID-19 vaccine Sputnik V in India.

[newsoutbursts]

Dr Reddy’s Reapplies For Clinical Trials Of Russian Covid Vaccine: Report Dr Reddy's reapplies for phases 2,3 clinical trials of Russian COVID-19 vaccine (Representational) New Delhi: The Hyderabad-based Dr Reddy's Laboratories has reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phases 2 and 3 human clinical trials of the Russian COVID-19 vaccine Sputnik V in India.

[telugugachips]

భారత్ లో కొత్త వాక్సిన్..రష్యా వాక్సిన్ ని విడుదల చేసిన డాక్టర్ రెడ్డీస్ ల్యాబ్

దిల్లీ: రష్యా అభివృద్ధి చేసిన కరోనా వ్యాక్సిన్‌ స్పుత్నిక్‌-వీ భారత్‌ మార్కెట్‌లో అందుబాటులోకి వచ్చింది. శుక్రవారం నుంచి అందుబాటులోకి వచ్చినట్లు డాక్టర్‌ రెడ్డీస్‌ ప్రకటించింది. స్పుత్నిక్‌ వీ ఒక్కో డోసు ధర రూ.948గా నిర్ణయించింది. దీనికి 5శాతం జీఎస్‌టీ కలిపితే టీకా ధర డోసుకు రూ.995.40. రష్యన్‌ డైరెక్ట్‌ ఇన్వెస్టిమెంట్‌ ఫండ్‌(ఆర్‌డీఐఎఫ్‌) సహకారంతో గమలేయా ఇన్‌స్టిట్యూట్‌ అభివృద్ధి చేసిన…

[newsupdated]

Dr Reddy’s Soars To Record High After Drug Maker Settles Patent Litigation In US Dr Reddy's Labs Share Price: The stock was among the top boosts to the NSE Nifty 50 index…

[newzzhub]

Dr Reddy’s Soars To Record High After Drug Maker Settles Patent Litigation In US Dr Reddy's Labs Share Price: The stock was among the top boosts to the NSE Nifty 50 index…

[trendingjagat]

Dr Reddy’s Laboratories Soars To Record After Drug Maker Settles Patent Litigation Dr Reddy's Labs shares were among the top boosts to the benchmark NSE Nifty 50 index…

[news24fresh]

Dr. Reddy’s launches OTC Nicotine Polacrilex Lozenges in U.S.

Dr. Reddy’s launches OTC Nicotine Polacrilex Lozenges in U.S.

[ad_1]

Pharma major Dr. Reddy’s Laboratories has launched over-the-counter Nicotine Polacrilex lozenges in the U.S. market.

The Nicotine lozenges brands and store brand markets had U.S. retail sales of around $200 million for the most recent 52 weeks ended May 17, 2020, the company said citing market research company IRI figures.

The OTC Nicotine Polacrilex lozenges, 2mg and 4mg, launched by…